Eqis Capital Management »

Heron Therapeutics shares owned by Eqis Capital Management

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Eqis Capital Management from 13F filings

Historical chart of Eqis Capital Management investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Eqis Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Eqis Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $30k 11k 2.77

More positions owned by Eqis Capital Management

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Index Fds Value Etf (VTV)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FJAN)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Wisdomtree Tr Us Midcap Fund (EZM)
Kraneshares Trust Kraneshares Valu (KVLE)
Pimco Etf Tr Active Bd Etf (BOND)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Intl Smcap Div (DLS)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Eqis Capital Management

Top funds holding Heron Therapeutics

Rubric Capital Management
OrbiMed Advisors
Vanguard Group
BlackRock
Velan Capital Investment Management
Franklin Resources
Tejara Capital
Palisade Capital Management
Millennium Management
Adage Capital Partners GP
Geode Capital Management
Clearline Capital
D. E. Shaw & Co
State Street Corporation
Renaissance Technologies

View all funds holding Heron Therapeutics